The EPLC and Swiss HLG are delighted to invite you to the 14th International Pharmaceutical Licensing Symposium; Peak Performance. To be held in Montreux, Switzerland, 19th – 21st September 2018.
Program-
This year the EPLC have put together a program with the theme of Peak Performance designed to help you evolve your deal-making in an ever-changing Business Development environment.
To take a look at the detailed program clickXIV-IPLS-Montreux-Programme-July-Update
Why you should register
Who should attend
Business Development Executives, General Managers, Directors, Owners, Executives in Marketing, Regulatory & Finance from the Healthcare sector, from all countries
SAVE THE DATE – for the Swiss HLG Annual Conference held at the scenic location Paxmontana Hotel near Lucerne from 31st January – 2nd February, 2021. Following the challenging year 2020, we will be glad to welcome you to exploit NEW HORIZONS.
We will discuss along with leading experts:
i. Recent evolution in deal-making, financing trends, and risk management in light of the 2020 experiences
ii. The impact of Digital Health technologies and partnering
iii. Creative accelerator as well as corporate structures to boost translation of innovation into new medicines
Don’t miss it – registration opens mid September.
IPLS Online Event: 16th – 17th September 2020
IPLS Bright Online Conference is now open for registration.
Full access to the event website where the presentations will be broadcast, video content, details of the programme and speakers & online partnering system. Full Access Pass – €100.00 (EUR).
Simply click here to register!
| 08.00 – 18.00 | Online Partnering – 25 minutes per meeting |
| MORNING SESSION | |
| 08.45 | Registration |
| 09.00 | Welcome & Introduction |
| 09.05 | Keynote Address SHAUN GRADY AstraZeneca |
| 09.25 | Covid-19: The First 6 Months ANDREW DEAN Present Value |
| 09.45 | Biopharmaceutical Sector: Financing and Deal Making Outlook STEPHANIE LEOUZON Torreya |
| 10.05 | Global Pipeline Overview |
| 10.25 | Closing Remarks |
| 10.30 | Close of Morning Session |
| AFTERNOON SESSION | |
| 15.15 – 15.30 | Registration |
| 15.30 | Innovation from The Crick BARBARA DOMAIN HAYMAN The Francis Crick Institute |
| 15.50 | What’s Hot in Oncology Deal Making- Where is the Low Hanging Fruit? CHRIS SHELDON AstraZeneca |
| 16.10 | Gene Therapy Comes of Age |
| 16.30 | BREAK |
| 16.40 | The Application of AI in Rare Diseases BRUCE E. BLOOM & CLARA TANG Healx |
| 17.00 | Pricing and Market Access in Rare Diseases RAVI SODHA Sodha Pharma Consulting |
| 17.20 | Closing Remarks |
| 17.25 | Close of Day 1 |
| 08.00 – 18.00 | Online Partnering – 25 minutes per meeting |
| 08.45 | Registration |
| 09.00 | Panel Discussion: Building Business Development Relationships in Covid-19 times GEORG BUCHNER Helsinn Healthcare CHRIS VAES J&J JEAN-MARC SEQUIER Novartis TORU J. SEO Pfizer MICHAEL CROWLEY F. Hoffann-La Roche |
| 09.45 | Panel Discussion: Impact of Covid-19 on Promotional Activities, Could Covid-19 Boost a Change of the Current Paradigm? LARS BOERGER Alliance Pharma BENOIT SLAVICEK Mundipharma |
| 10.30 | Closing Remarks |
| 10.35 | Close of IPLS Bright Online |
Adapting ongoing clinical trials
Adapting business plans and operations
Industrial association and government resources
Health authority guidelines
Swiss task forces and initiatives
Partnering & collaboration resources
Sales & marketing resources
Scientific/academic publications
Scientific materials and tools (reference samples etc)
Diagnostic, Therapeutic & Vaccine developments
Heathcare Conferences
Hackathon
Interesting Reads / Literature
With the current situation of Corona virus pandemic, the Swiss HLG board decided to cancel the Summer Conference 2020, which was scheduled to take place on 18th June 2020. The board is working on an alternative date which shall be communicated in due time.
Swiss HLG has contemplated a conversion of the event to a remote or virtual conference, as did some of the BD&L conferences, however Networking being one of our cornerstones, we preferred to postpone to a better time when we will be able to maintain our traditional conferences with the one-on-one interactions.
We are confident that you would understand and we thank you for your support.
We wish you and your family healthy weeks ahead.
